Skip to main content
Top
Published in: Surgical Endoscopy 12/2021

Open Access 01-12-2021 | Cholecystectomy

The minimally important difference of the Gastrointestinal Quality of Life Index for symptomatic gallstone surgery

Authors: Jason M. Sutherland, Carmela Melina Albanese, Trafford Crump, Guiping Liu, Ahmer Karimuddin

Published in: Surgical Endoscopy | Issue 12/2021

Login to get access

Abstract

Introduction

The Gastrointestinal Quality of Life Index (GQLI) is used to measure domains of health and symptoms among people with gastrointestinal disorders. The objective of this study is to calculate the smallest change in the GQLI that is perceived by patients as meaningful among a sample of English-speaking adult patients undergoing elective laparoscopic cholecystectomy for treatment of symptomatic gallbladder disease.

Materials and methods

The study is based on retrospective analyses of a sample of participants completing the GQLI and the EQ-5D(3L) preoperatively and six months postoperatively in Vancouver, Canada. Patients are excluded if they are less than 19 years of age, cannot communicate in English, or reside in a long-term care facility. The MID is calculated for the GQLI’s domains using distribution and anchor-based methods.

Results

Among eligible patients, the participation rate was 51%. The estimated MID for the overall GQLI value ranged between 4.32 and 11.44. There were no statistically significant differences in the GQLI’s MID values between sexes or age subgroups. There were statistically significant differences in the GQLI’s MID values by baseline health status.

Discussion

This study should provide some comfort that the MID values used in discussing change in health and symptoms with elective cholecystectomy patients are robust to sex. Although the sample size may have been inadequate for age-based analyses, the study found large differences in MID values between age subgroups. Statistically significant differences in MID values based on preoperative health supports reporting MID values separately by baseline value. Further research should explore whether age-based differences in MID values exist using larger samples.
Appendix
Available only for authorised users
Literature
1.
go back to reference Revicki D, Hays RD, Cella D, Sloan J (2008) Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes. J Clin Epidemiol 61(2):102–109PubMedCrossRef Revicki D, Hays RD, Cella D, Sloan J (2008) Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes. J Clin Epidemiol 61(2):102–109PubMedCrossRef
2.
go back to reference Weldring T, Smith SMS (2013) Patient-reported outcomes (PROs) and patient-reported outcome measures (PROMs). Heal Serv Insights 6:61–68 Weldring T, Smith SMS (2013) Patient-reported outcomes (PROs) and patient-reported outcome measures (PROMs). Heal Serv Insights 6:61–68
3.
go back to reference Kingsley C, Patel S (2017) Patient-reported outcome measures and patient-reported experience measures. BJA Educ 17(4):137–144CrossRef Kingsley C, Patel S (2017) Patient-reported outcome measures and patient-reported experience measures. BJA Educ 17(4):137–144CrossRef
4.
go back to reference Eypasch E, Williams JI, Wood-Dauphinee S, Ure BM, Schmülling C, Neugebauer E et al (1995) Gastrointestinal Quality of Life Index: development, validation and application of a new instrument. Br J Surg 82(2):216–222CrossRef Eypasch E, Williams JI, Wood-Dauphinee S, Ure BM, Schmülling C, Neugebauer E et al (1995) Gastrointestinal Quality of Life Index: development, validation and application of a new instrument. Br J Surg 82(2):216–222CrossRef
5.
go back to reference Gurusamy KS, Davidson BR (2019) Gallstone disease. In: McDonald JWD, Feagan BG, Jalan R, Kahrilas PJ (eds) Evidence-based gastroenterology and hepatology, 4th edn. Wiley, New York, pp 342–352CrossRef Gurusamy KS, Davidson BR (2019) Gallstone disease. In: McDonald JWD, Feagan BG, Jalan R, Kahrilas PJ (eds) Evidence-based gastroenterology and hepatology, 4th edn. Wiley, New York, pp 342–352CrossRef
6.
go back to reference Brazzelli M, Cruickshank M, Kilonzo M, Ahmed I, Stewart F, Mcnamee P et al (2014) Clinical effectiveness and cost-effectiveness of cholecystectomy compared with observation/conservative management for preventing recurrent symptoms and complications in adults presenting with uncomplicated symptomatic gallstones or cholecystitis: a syste. Health Technol Assess (Rockv) 18(55):1–102CrossRef Brazzelli M, Cruickshank M, Kilonzo M, Ahmed I, Stewart F, Mcnamee P et al (2014) Clinical effectiveness and cost-effectiveness of cholecystectomy compared with observation/conservative management for preventing recurrent symptoms and complications in adults presenting with uncomplicated symptomatic gallstones or cholecystitis: a syste. Health Technol Assess (Rockv) 18(55):1–102CrossRef
7.
go back to reference Mcdonald JWD, Feagan BG, Jalan R, Kahrilas PJ (2019) Evidence-based gastroenterology and hepatology, 4th edn. Wiley, Hoboken, p 816 Mcdonald JWD, Feagan BG, Jalan R, Kahrilas PJ (2019) Evidence-based gastroenterology and hepatology, 4th edn. Wiley, Hoboken, p 816
8.
go back to reference Mentes BB, Akin M, Irkorucu O, Tatlicioglu E, Ferahkose Z, Yildirim A et al (2001) Gastrointestinal quality of life in patients with symptomatic or asymptomatic cholelithiasis before and after laparoscopic cholecystectomy. Surg Endosc 15:1267–1272PubMedCrossRef Mentes BB, Akin M, Irkorucu O, Tatlicioglu E, Ferahkose Z, Yildirim A et al (2001) Gastrointestinal quality of life in patients with symptomatic or asymptomatic cholelithiasis before and after laparoscopic cholecystectomy. Surg Endosc 15:1267–1272PubMedCrossRef
9.
go back to reference Sandblom G, Videhult P, Karlson B, Wollert S, Darkahi B, Ljungdahl M et al (2007) Validation of gastrointestinal Quality of Life Index for assessment of gallstone-related symptoms. Value Health 10:A151–A152CrossRef Sandblom G, Videhult P, Karlson B, Wollert S, Darkahi B, Ljungdahl M et al (2007) Validation of gastrointestinal Quality of Life Index for assessment of gallstone-related symptoms. Value Health 10:A151–A152CrossRef
10.
go back to reference Sandblom G, Videhult P, Karlson BM, Wollert S, Ljungdahl M, Darkahi B et al (2009) Validation of gastrointestinal quality of life index in Swedish for assessing the impact of gallstones on health-related quality of life. Value Health 12(1):181–184PubMedCrossRef Sandblom G, Videhult P, Karlson BM, Wollert S, Ljungdahl M, Darkahi B et al (2009) Validation of gastrointestinal quality of life index in Swedish for assessing the impact of gallstones on health-related quality of life. Value Health 12(1):181–184PubMedCrossRef
11.
go back to reference Lien H-H, Huang C-C, Wang P-C, Chen Y-H, Huang C-S, Lin T-L et al (2007) Validation assessment of the Chinese (Taiwan) version of the Gastrointestinal Quality of Life Index for patients with symptomatic gallstone disease. J Laparoendosc Adv Surg Technol A 17(4):429–434CrossRef Lien H-H, Huang C-C, Wang P-C, Chen Y-H, Huang C-S, Lin T-L et al (2007) Validation assessment of the Chinese (Taiwan) version of the Gastrointestinal Quality of Life Index for patients with symptomatic gallstone disease. J Laparoendosc Adv Surg Technol A 17(4):429–434CrossRef
12.
go back to reference Hsueh L-N, Shi H-Y, Wang T-F, Chang C-Y, Lee K-T (2011) Health-related quality of life in patients undergoing cholecystectomy. Kaohsiung J Med Sci 27(7):280–288PubMedCrossRef Hsueh L-N, Shi H-Y, Wang T-F, Chang C-Y, Lee K-T (2011) Health-related quality of life in patients undergoing cholecystectomy. Kaohsiung J Med Sci 27(7):280–288PubMedCrossRef
13.
go back to reference Quintana JM, Arostegui I, Oribe V, de Tejada L, Barrios B, Garay I (2005) Influence of age and gender on quality-of-life outcomes after cholecystectomy. Qual Life Res 14:815–825PubMedCrossRef Quintana JM, Arostegui I, Oribe V, de Tejada L, Barrios B, Garay I (2005) Influence of age and gender on quality-of-life outcomes after cholecystectomy. Qual Life Res 14:815–825PubMedCrossRef
14.
go back to reference Fillingim RB, King CD, Ribeiro-Dasilva MC, Rahim-Williams B, Riley JLI (2009) Sex, gender, and pain: a review of recent clinical and experimental findings. J Pain 10(5):447–485PubMedPubMedCentralCrossRef Fillingim RB, King CD, Ribeiro-Dasilva MC, Rahim-Williams B, Riley JLI (2009) Sex, gender, and pain: a review of recent clinical and experimental findings. J Pain 10(5):447–485PubMedPubMedCentralCrossRef
15.
go back to reference Wanjura V, Lundström P, Österberg J, Rasmussen I, Karlson BM, Sandblom G (2014) Gastrointestinal quality-of-life after cholecystectomy: indication predicts gastrointestinal symptoms and abdominal pain. World J Surg 38(12):3075–3081PubMedCrossRef Wanjura V, Lundström P, Österberg J, Rasmussen I, Karlson BM, Sandblom G (2014) Gastrointestinal quality-of-life after cholecystectomy: indication predicts gastrointestinal symptoms and abdominal pain. World J Surg 38(12):3075–3081PubMedCrossRef
16.
go back to reference Jaeschke R, Singer J, Guyatt GH (1989) Ascertaining the minimal clinically important difference. Control Clin Trials 10:407–415PubMedCrossRef Jaeschke R, Singer J, Guyatt GH (1989) Ascertaining the minimal clinically important difference. Control Clin Trials 10:407–415PubMedCrossRef
17.
go back to reference Guyatt GH, Osoba D, Wu AW, Wyrwich KW, Norman GR, Aaronson N et al (2002) Methods to explain the clinical significance of health status measures. Mayo Clin Proc 77(4):371–383PubMedCrossRef Guyatt GH, Osoba D, Wu AW, Wyrwich KW, Norman GR, Aaronson N et al (2002) Methods to explain the clinical significance of health status measures. Mayo Clin Proc 77(4):371–383PubMedCrossRef
18.
go back to reference King MT (2011) A point of minimal important difference (MID): a critique of terminology and methods. Expert Rev Pharmacoecon Outcomes Res 11(2):171–184PubMedCrossRef King MT (2011) A point of minimal important difference (MID): a critique of terminology and methods. Expert Rev Pharmacoecon Outcomes Res 11(2):171–184PubMedCrossRef
19.
go back to reference Willke R, Burke L, Erickson P (2004) Measuring treatment impact: a review of patient-reported outcomes and other efficacy endpoints in approved product labels. Control Clin Trials 25(6):535–552PubMedCrossRef Willke R, Burke L, Erickson P (2004) Measuring treatment impact: a review of patient-reported outcomes and other efficacy endpoints in approved product labels. Control Clin Trials 25(6):535–552PubMedCrossRef
20.
go back to reference Revicki DA, Cella D, Hays RD, Sloan JA, Lenderking WR, Aaronson NK (2006) Responsiveness and minimal important differences for patient reported outcomes. Health Qual Life Outcomes 4:1–5CrossRef Revicki DA, Cella D, Hays RD, Sloan JA, Lenderking WR, Aaronson NK (2006) Responsiveness and minimal important differences for patient reported outcomes. Health Qual Life Outcomes 4:1–5CrossRef
21.
go back to reference Devlin N, Parkin D, Janssen B (2020) Methods for analysing and reporting EQ-5D data. Springer, SwitzerlandCrossRef Devlin N, Parkin D, Janssen B (2020) Methods for analysing and reporting EQ-5D data. Springer, SwitzerlandCrossRef
22.
go back to reference Shi H-Y, Lee K-T, Lee H-H, Uen Y-H, Na H-L, Chao F-T et al (2009) The minimal clinically important difference in the Gastrointestinal Quality-of-Life Index after cholecystectomy. Surg Endosc 23:2708–2712PubMedCrossRef Shi H-Y, Lee K-T, Lee H-H, Uen Y-H, Na H-L, Chao F-T et al (2009) The minimal clinically important difference in the Gastrointestinal Quality-of-Life Index after cholecystectomy. Surg Endosc 23:2708–2712PubMedCrossRef
23.
go back to reference Sutherland J, Liu G, Crump T, Bair M, Karimuddin A (2018) Relationship between preoperative patient-reported outcomes and hospital length of stay: a prospective cohort study of general surgery patients in Vancouver, Canada. J Health Serv Res Policy 24:29PubMedCrossRef Sutherland J, Liu G, Crump T, Bair M, Karimuddin A (2018) Relationship between preoperative patient-reported outcomes and hospital length of stay: a prospective cohort study of general surgery patients in Vancouver, Canada. J Health Serv Res Policy 24:29PubMedCrossRef
24.
go back to reference Sutherland JM, Crump RT, Chan A, Liu G, Yue E, Bair M (2016) Health of patients on the waiting list: opportunity to improve health in Canada? Health Policy (New York) 120(7):749–757CrossRef Sutherland JM, Crump RT, Chan A, Liu G, Yue E, Bair M (2016) Health of patients on the waiting list: opportunity to improve health in Canada? Health Policy (New York) 120(7):749–757CrossRef
25.
go back to reference Lien HH, Huang CC, Wang PC, Huang CS, Chen YH, Lin TL et al (2009) Changes in quality-of-life following laparoscopic cholecystectomy in adult patients with cholelithiasis. J Gastrointest Surg 14(1):126–130PubMedCrossRef Lien HH, Huang CC, Wang PC, Huang CS, Chen YH, Lin TL et al (2009) Changes in quality-of-life following laparoscopic cholecystectomy in adult patients with cholelithiasis. J Gastrointest Surg 14(1):126–130PubMedCrossRef
26.
go back to reference EuroQoL Group (1990) EuroQol-a new facility for the measurement of health-related quality of life. Health Policy (New York) 16(3):199–208CrossRef EuroQoL Group (1990) EuroQol-a new facility for the measurement of health-related quality of life. Health Policy (New York) 16(3):199–208CrossRef
27.
go back to reference Brooks R (1996) EuroQol: the current state of play. Health Policy 37(1):53–72CrossRef Brooks R (1996) EuroQol: the current state of play. Health Policy 37(1):53–72CrossRef
28.
29.
go back to reference Dolan P (1996) The effect of experience of illness on health state valuations. J Clin Epidemiol 49(5):551–564PubMedCrossRef Dolan P (1996) The effect of experience of illness on health state valuations. J Clin Epidemiol 49(5):551–564PubMedCrossRef
30.
go back to reference Bansback N, Tsuchiya A, Brazier J, Anis A (2012) Canadian valuation of EQ-5D health states: preliminary value set and considerations for future valuation studies. PLoS ONE 7(2):e3111CrossRef Bansback N, Tsuchiya A, Brazier J, Anis A (2012) Canadian valuation of EQ-5D health states: preliminary value set and considerations for future valuation studies. PLoS ONE 7(2):e3111CrossRef
31.
go back to reference Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40(5):373–383PubMedCrossRef Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40(5):373–383PubMedCrossRef
32.
go back to reference Lydick E, Epstein RS (1993) Interpretation of quality of life changes. Qual Life Res 2(3):221–226PubMedCrossRef Lydick E, Epstein RS (1993) Interpretation of quality of life changes. Qual Life Res 2(3):221–226PubMedCrossRef
33.
go back to reference Norman GR, Sloan JA, Wyrwich KW (2003) Interpretation of changes in health-related quality of life the remarkable universality of half a standard deviation. Med Care 41(5):582–592PubMedCrossRef Norman GR, Sloan JA, Wyrwich KW (2003) Interpretation of changes in health-related quality of life the remarkable universality of half a standard deviation. Med Care 41(5):582–592PubMedCrossRef
34.
go back to reference Coretti S, Ruggeri M, McNamee P (2014) The minimum clinically important difference for EQ-5D index: a critical review. Expert Rev Pharmacoecon Outcomes Res 14(2):221–233PubMedCrossRef Coretti S, Ruggeri M, McNamee P (2014) The minimum clinically important difference for EQ-5D index: a critical review. Expert Rev Pharmacoecon Outcomes Res 14(2):221–233PubMedCrossRef
35.
go back to reference Copay AG, Subach BR, Glassman SD, Polly DW, Schuler TC (2007) Understanding the minimum clinically important difference: a review of concepts and methods. Spine J 7(5):541–546PubMedCrossRef Copay AG, Subach BR, Glassman SD, Polly DW, Schuler TC (2007) Understanding the minimum clinically important difference: a review of concepts and methods. Spine J 7(5):541–546PubMedCrossRef
36.
go back to reference Sloan JA, Cella D, Hays RD (2005) Clinical significance of patient-reported questionnaire data: another step toward consensus. J Clin Epidemiol 58(12):1217–1219PubMedCrossRef Sloan JA, Cella D, Hays RD (2005) Clinical significance of patient-reported questionnaire data: another step toward consensus. J Clin Epidemiol 58(12):1217–1219PubMedCrossRef
37.
go back to reference Rejas J, Pardo A, Ruiz MÁ (2008) Standard error of measurement as a valid alternative to minimally important difference for evaluating the magnitude of changes in patient-reported outcomes measures. J Clin Epidemiol 61(4):350–356PubMedCrossRef Rejas J, Pardo A, Ruiz MÁ (2008) Standard error of measurement as a valid alternative to minimally important difference for evaluating the magnitude of changes in patient-reported outcomes measures. J Clin Epidemiol 61(4):350–356PubMedCrossRef
38.
go back to reference Schünemann HJ, Griffith L, Jaeschke R, Goldstein R, Stubbing D, Guyatt GH (2003) Evaluation of the minimal important difference for the feeling thermometer and the St. George’s Respiratory Questionnaire in patients with chronic airflow obstruction. J Clin Epidemiol 56(12):1170–1176PubMedCrossRef Schünemann HJ, Griffith L, Jaeschke R, Goldstein R, Stubbing D, Guyatt GH (2003) Evaluation of the minimal important difference for the feeling thermometer and the St. George’s Respiratory Questionnaire in patients with chronic airflow obstruction. J Clin Epidemiol 56(12):1170–1176PubMedCrossRef
39.
go back to reference Puhan MA, Frey M, Büchi S, Schünemann HJ (2008) The minimal important difference of the hospital anxiety and depression scale in patients with chronic obstructive pulmonary disease. Health Qual Life Outcomes 6:1–6CrossRef Puhan MA, Frey M, Büchi S, Schünemann HJ (2008) The minimal important difference of the hospital anxiety and depression scale in patients with chronic obstructive pulmonary disease. Health Qual Life Outcomes 6:1–6CrossRef
40.
go back to reference Simon AS, Neary MP, Cella D (2007) Estimation of minimally important differences in EQ-5D utility and VAS scores in cancer. Health Qual Life Outcomes 5:2–9 Simon AS, Neary MP, Cella D (2007) Estimation of minimally important differences in EQ-5D utility and VAS scores in cancer. Health Qual Life Outcomes 5:2–9
41.
go back to reference McClure N, Sayah F, Xie F, Luo N, Johnson J (2017) Instrument-defined estimates of the minimally important difference for EQ-5D-5L Index Scores. Value Health 20(4):644–650CrossRef McClure N, Sayah F, Xie F, Luo N, Johnson J (2017) Instrument-defined estimates of the minimally important difference for EQ-5D-5L Index Scores. Value Health 20(4):644–650CrossRef
42.
go back to reference Le QA, Doctor JN, Zoellner LA, Feeny NC (2013) Minimal clinically important differences for the EQ-5D and QWB-SA in Post-traumatic Stress Disorder (PTSD): results from a doubly randomized preference trial (DRPT). Health Qual Life Outcomes 11(1):1–9CrossRef Le QA, Doctor JN, Zoellner LA, Feeny NC (2013) Minimal clinically important differences for the EQ-5D and QWB-SA in Post-traumatic Stress Disorder (PTSD): results from a doubly randomized preference trial (DRPT). Health Qual Life Outcomes 11(1):1–9CrossRef
43.
go back to reference Walters SJ, Brazier JE (2005) Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D. Qual Life Res 14(6):1523–1532PubMedCrossRef Walters SJ, Brazier JE (2005) Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D. Qual Life Res 14(6):1523–1532PubMedCrossRef
44.
go back to reference Team RC (2017) R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna Team RC (2017) R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna
Metadata
Title
The minimally important difference of the Gastrointestinal Quality of Life Index for symptomatic gallstone surgery
Authors
Jason M. Sutherland
Carmela Melina Albanese
Trafford Crump
Guiping Liu
Ahmer Karimuddin
Publication date
01-12-2021
Publisher
Springer US
Keyword
Cholecystectomy
Published in
Surgical Endoscopy / Issue 12/2021
Print ISSN: 0930-2794
Electronic ISSN: 1432-2218
DOI
https://doi.org/10.1007/s00464-020-08205-z

Other articles of this Issue 12/2021

Surgical Endoscopy 12/2021 Go to the issue